HS-based Therapies for Ischaemic Stroke: Opportunities and Challenges

Overview

Journal Stroke Vasc Neurol

Specialty Cardiology & Vascular Diseases

Date 2019 Jul 25

PMID 31338211

Citations 12

Authors

Jia Jia

Jie Li

Jian Cheng

Affiliations

Soon will be listed here.

Abstract

Stroke is a cerebrovascular disease displaying high mortality and morbidity. Despite extensive efforts, only very few therapies are available for stroke patients as yet. Hydrogen sulfide (HS) is thought to be a signalling molecule that is endogenously produced and plays functional roles in the central nervous system. Currently, numerous studies show that HS impacts stroke outcomes in animal and cellular models. Here, we review the recent research regarding the effects of endogenously produced HS as well as exogenous HS donors on stroke pathology, focusing on the potential of HS-based therapies in treating ischaemic stroke. We also discuss the several issues that hinder the clinical translation of HS-based therapies from the bench. Taken together, we think that HS-based therapies are promising strategies for treating cerebral ischaemia if we successfully address these issues.

Citing Articles

GYY4137 ameliorates blood brain barrier damage by inhibiting autophagy mediated occludin degradation in cardiac arrest and resuscitation.

Duan P, Li X, Bi Y, Feng W, Jin Z, Zhang X Sci Rep. 2025; 15(1):905.

PMID: 39762518 PMC: 11704213. DOI: 10.1038/s41598-024-84948-2.

A meta-analysis of animal studies evaluating the effect of hydrogen sulfide on ischemic stroke: is the preclinical evidence sufficient to move forward?.

Emre Aydingoz S, Teimoori A, Orhan H, Demirtas E, Zeynalova N Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):9533-9548.

PMID: 39017715 PMC: 11582254. DOI: 10.1007/s00210-024-03291-5.

Cerebroprotective actions of hydrogen sulfide in the epileptic brain in newborn pigs.

Liu J, Pourcyrous M, Fedinec A, Parfenova H Pediatr Res. 2023; 94(2):495-502.

PMID: 36694027 PMC: 10363572. DOI: 10.1038/s41390-023-02486-5.

Research Progress of HS Donors Conjugate Drugs Based on ADTOH.

Wen S, Cao C, Ge J, Yang W, Wang Y, Mou Y Molecules. 2023; 28(1).

PMID: 36615525 PMC: 9822322. DOI: 10.3390/molecules28010331.

Therapeutic applications of hydrogen sulfide and novel donors for cerebral ischemic stroke: a narrative review.

Ding J, Zhang Y, Wang T, Li X, Ma C, Xu Z Med Gas Res. 2022; 13(1):7-9.

PMID: 35946216 PMC: 9480360. DOI: 10.4103/2045-9912.350863.

References

Bian J, Yong Q, Pan T, Feng Z, Ali M, Zhou S . Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther. 2005; 316(2):670-8. DOI: 10.1124/jpet.105.092023. View

Qu K, Chen C, Halliwell B, Moore P, Wong P . Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke. 2006; 37(3):889-93. DOI: 10.1161/01.STR.0000204184.34946.41. View

Wong P, Qu K, Chimon G, Seah A, Chang H, Wong M . High plasma cyst(e)ine level may indicate poor clinical outcome in patients with acute stroke: possible involvement of hydrogen sulfide. J Neuropathol Exp Neurol. 2006; 65(2):109-15. DOI: 10.1097/01.jnen.0000199571.96472.c7. View

Qu K, Lee S, Bian J, Low C, Wong P . Hydrogen sulfide: neurochemistry and neurobiology. Neurochem Int. 2007; 52(1-2):155-65. DOI: 10.1016/j.neuint.2007.05.016. View

Cheung N, Peng Z, Chen M, Moore P, Whiteman M . Hydrogen sulfide induced neuronal death occurs via glutamate receptor and is associated with calpain activation and lysosomal rupture in mouse primary cortical neurons. Neuropharmacology. 2007; 53(4):505-14. DOI: 10.1016/j.neuropharm.2007.06.014. View

Volpato G, Searles R, Yu B, Scherrer-Crosbie M, Bloch K, Ichinose F . Inhaled hydrogen sulfide: a rapidly reversible inhibitor of cardiac and metabolic function in the mouse. Anesthesiology. 2008; 108(4):659-68. PMC: 2838418. DOI: 10.1097/ALN.0b013e318167af0d. View

Li L, Whiteman M, Guan Y, Neo K, Cheng Y, Lee S . Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation. 2008; 117(18):2351-60. DOI: 10.1161/CIRCULATIONAHA.107.753467. View

Florian B, Vintilescu R, Balseanu A, Buga A, Grisk O, Walker L . Long-term hypothermia reduces infarct volume in aged rats after focal ischemia. Neurosci Lett. 2008; 438(2):180-5. DOI: 10.1016/j.neulet.2008.04.020. View

Lee M, Schwab C, Yu S, McGeer E, McGeer P . Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol Aging. 2009; 30(10):1523-34. DOI: 10.1016/j.neurobiolaging.2009.06.001. View

10.

Tan B, Wong P, Bian J . Hydrogen sulfide: a novel signaling molecule in the central nervous system. Neurochem Int. 2009; 56(1):3-10. DOI: 10.1016/j.neuint.2009.08.008. View

11.

Lee M, Tazzari V, Giustarini D, Rossi R, Sparatore A, Del Soldato P . Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease. J Biol Chem. 2010; 285(23):17318-28. PMC: 2878495. DOI: 10.1074/jbc.M110.115261. View

12.

Ren C, Du A, Li D, Sui J, Mayhan W, Zhao H . Dynamic change of hydrogen sulfide during global cerebral ischemia-reperfusion and its effect in rats. Brain Res. 2010; 1345:197-205. DOI: 10.1016/j.brainres.2010.05.017. View

13.

Moskowitz M, Lo E, Iadecola C . The science of stroke: mechanisms in search of treatments. Neuron. 2010; 67(2):181-98. PMC: 2957363. DOI: 10.1016/j.neuron.2010.07.002. View

14.

Bouillaud F, Blachier F . Mitochondria and sulfide: a very old story of poisoning, feeding, and signaling?. Antioxid Redox Signal. 2010; 15(2):379-91. DOI: 10.1089/ars.2010.3678. View

15.

Kabil O, Vitvitsky V, Xie P, Banerjee R . The quantitative significance of the transsulfuration enzymes for H2S production in murine tissues. Antioxid Redox Signal. 2011; 15(2):363-72. PMC: 3118817. DOI: 10.1089/ars.2010.3781. View

16.

Marutani E, Kosugi S, Tokuda K, Khatri A, Nguyen R, Atochin D . A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal death. J Biol Chem. 2012; 287(38):32124-35. PMC: 3442543. DOI: 10.1074/jbc.M112.374124. View

17.

Wei X, Duan L, Bai L, Tian M, Li W, Zhang B . Effects of exogenous hydrogen sulfide on brain metabolism and early neurological function in rabbits after cardiac arrest. Intensive Care Med. 2012; 38(11):1877-85. DOI: 10.1007/s00134-012-2714-x. View

18.

Kabil O, Banerjee R . Enzymology of H2S biogenesis, decay and signaling. Antioxid Redox Signal. 2013; 20(5):770-82. PMC: 3910450. DOI: 10.1089/ars.2013.5339. View

19.

Zhao H, Chan S, Ng Y, Wong P . Brain 3-Mercaptopyruvate Sulfurtransferase (3MST): Cellular Localization and Downregulation after Acute Stroke. PLoS One. 2013; 8(6):e67322. PMC: 3689812. DOI: 10.1371/journal.pone.0067322. View

20.

Zhou X, Cao Y, Ao G, Hu L, Liu H, Wu J . CaMKKβ-dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation. Antioxid Redox Signal. 2014; 21(12):1741-58. PMC: 5695757. DOI: 10.1089/ars.2013.5587. View